Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.

@article{Hirsch2015ActivityOF,
  title={Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.},
  author={Elizabeth B. Hirsch and Brian R. Raux and P. Zucchi and Yi-Sun Kim and Christopher M McCoy and J. Kirby and S. B. Wright and G. Eliopoulos},
  journal={International journal of antimicrobial agents},
  year={2015},
  volume={46 6},
  pages={
          642-7
        }
}
Fosfomycin is recommended as first-line treatment for acute uncomplicated cystitis in women. It has demonstrated in vitro activity against a variety of pathogens; however, a paucity of data are available from the USA. We determined the susceptibility of a collection of urine isolates to fosfomycin and compared multiple methods of susceptibility testing. Consecutive non-duplicate Enterobacteriaceae, enterococci and Pseudomonas aeruginosa isolates were collected from the clinical microbiology… Expand
The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates
TLDR
FosA influences the inaccuracy of susceptibility testing by methods readily available in a clinical laboratory when compared to agar dilution, and further research is needed to determine the impact of fosA on clinical outcomes. Expand
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates
TLDR
Results indicate that broth microdilution may be a reliable method for fosfomycin susceptibility testing against P. aeruginosa and stress the need for P.aerugInosa-specific breakpoints. Expand
The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates
TLDR
FosA influences the inaccuracy of susceptibility testing by methods readily available in a clinical laboratory compared to agar dilution, and further research is needed to determine the impact of fosA on clinical outcomes. Expand
Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
TLDR
Although nitrofurantoin has been widely prescribed for the treatment of UTIs for the past several years, it was still found to be active in vitro against the urinary isolates of MDR enterococci, including VRE. Expand
In vitro Assessment of Fosfomycin: A Beacon of Hope in Drug Resistant Organisms Causing Urinary Tract Infections
TLDR
This study suggests that fosfomycin has the potential to replace the parenteral antibiotics for treating complicated or hospital acquired lower UTI especially in case of Enterobacteriaceae. Expand
Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusion
TLDR
None of the test methods is suitable as an alternative to agar dilution in the routine laboratory for fosfomycin susceptibility testing and none adequately differentiated between WT and non-WT populations. Expand
Fosfomycin Susceptibility in Multidrug-Resistant Enterobacteriaceae Species and Vancomycin-Resistant Enterococci Urinary Isolates.
TLDR
To explore a cost-effective alternative for the treatment of lower UTIs caused by multidrug-resistant Enterobacteriaceae and VRE organisms resistant to usual first-line therapies, fosfomycin was deemed the most reliable oral option. Expand
Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes
TLDR
This retrospective study adds to the limited literature exploring alternative therapies for complicated and MDR UTIs with results providing additional evidence that fosfomycin may be an effective oral option. Expand
Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods
TLDR
Performing fosfomycin disk diffusion or Etest on urinary isolates of E. coli and interpreting results using CLSI breakpoints reliably identified fosFomycin-susceptible isolates regardless of differences in endpoint reading criteria, as well as EUCAST breakpoints. Expand
Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model
TLDR
Using dynamic in vitro simulations of urinary fosfomycin exposures, E. coli and E. pneumoniae isolates were killed with pharmacokinetic/pharmacodynamic EI50 of fAUC0-24/MIC’s’= 1922, fCmax/ MIC =‬149 and fTime>4×MIC‬44 h, and the utility of fosFomycin against K. pneumoniaes was questioned. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 17 REFERENCES
Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
TLDR
Fosfomycin demonstrated in vitro activity against UTIs due to MDR pathogens, and multiple confounding factors may have contributed to microbiological failures. Expand
Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
TLDR
New tentative zone diameter criteria for K. pneumoniae, E. aureus, and E. faecium were able to be set, providing some interim laboratory guidance for disk diffusion until further breakpoint evaluations are undertaken by CLSI and EUCAST. Expand
Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods
TLDR
Fosfomycin may be a treatment option for multiresistant Gram-negative bacteria and CLSI criteria for urine may be adequate for systemic infections. Expand
Susceptibility of Urinary Tract Bacteria to Fosfomycin
TLDR
Fosfomycin appears to exhibit good levels of in vitro activity against urinary isolates in a region in Greece that exhibits considerable antimicrobial resistance by evaluating retrospectively relevant susceptibility data retrieved from the microbiological library. Expand
Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae.
TLDR
All strains with intermediate susceptibility to fosfomycin were evaluated and Etest results were compared with agar dilution values and discrepancies of more than 4-fold were repeated, becoming the definitive result. Expand
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
TLDR
Fosfomycin represents a potential last-resort treatment option for infections with certain multidrug-resistant (MDR) Gram-negative pathogens and in vitro synergy against 100 MDR Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates was observed. Expand
Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Coresistance Phenotype among Recent Escherichia coli Isolates from U.S. Veterans
TLDR
Findings identify potential alternative oral agents for use with E. coli isolates resistant to fluoroquinolones, ESCs, and/or TMP-SMZ and suggest that determination of ST131 status could help guide initial antimicrobial selection, pending susceptibility results. Expand
Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
TLDR
The antibiotic susceptibility of 164 isolates of Escherichia coli from the urine of 164 patients with community-acquired urinary tract infection was determined to take into account the type of UTI, previous antimicrobial therapy, and the sex and age of each patient. Expand
In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
TLDR
In vitro activity of fosfomycin was evaluated against 68 blaKPC-possessing Klebsiella pneumoniae isolates, including 23 tigecycline- and/or colistin-nonsusceptible strains, and 5 out of 6 extremely drug-resistant KpKPC were susceptible to fosFomycin. Expand
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.
TLDR
In this study fosfomycin exhibited good in vitro antimicrobial activity against MDR and XDR Enterobacteriaceae, and it is suggested that further evaluation of the potential clinical utility of fosFomycin against infections caused by these pathogens is suggested. Expand
...
1
2
...